Status:
COMPLETED
Study Of Asthma In Patients Of African Descent
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
12-65 years
Phase:
PHASE4
Brief Summary
This study will last up to 62 weeks. You will visit the clinic up to 17 times. Certain clinic visits will include physical examination, medical history review and lung function tests. The purpose of t...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- History of asthma for at least 6 months.
- Taking a low-dose of an inhaled corticosteroid for at least one month prior to the study (such as fluticasone propionate or budesonide).
- Exclusion criteria:
- History of life-threatening asthma.
- Hospitalized for asthma within 3 months prior to the study.
- Current respiratory tract infection.
- Will not be able to attend clinic visits for the entire length of the study.
- Certain medical conditions that will make being in the study unsafe (such as congestive heart failure, uncontrolled hypertension, tuberculosis or certain drug allergies).
Exclusion
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
479 Patients enrolled
Trial Details
Trial ID
NCT00102765
Start Date
November 1 2004
End Date
April 1 2007
Last Update
January 18 2017
Active Locations (75)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Birmingham, Alabama, United States, 35205
2
GSK Investigational Site
Birmingham, Alabama, United States, 35209
3
GSK Investigational Site
Birmingham, Alabama, United States, 35294-0012
4
GSK Investigational Site
Mobile, Alabama, United States, 36608